Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer

10.1111/bcp.13218

Saved in:

Bibliographic Details
Main Authors:	Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Rieder, Michael J, Bhavsar, Amit P, Sanatani, Shubhayan, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Other Authors:	MEDICINE
Format:	Letter
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy anthracycline anthracycline-induced cardiotoxicity cancer chemotherapy clinical practice guidelines congestive heart failure pharmacogenomic screening DOXORUBICIN-INDUCED CARDIOTOXICITY RECOMMENDATIONS UGT1A6 IDENTIFICATION REACTIVITY METABOLITE TOXICITY CHILDREN GRADE CELLS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235058
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
by: Aminkeng, Folefac, et al.
Published: (2022)

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
by: Dionne, Francois, et al.
Published: (2022)

Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population
by: Tan, VZZ, et al.
Published: (2021)

The emerging era of pharmacogenomics: current successes, future potential, and challenges
by: Lee, JW, et al.
Published: (2022)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Cheah, Irwin K, et al.
Published: (2023)

Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice
by: Chua, C.C., et al.
Published: (2011)

Multifactorial Prediction of Anthracycline-Induced Cardiotoxicity in Childhood Cancer: 10 Years of Active Surveillance and Pharmacogenomics Studies at the Canadian Pharmacogenomics Network for Drug Safety
by: Aminkeng, Folefac, et al.
Published: (2022)

NA+/K+ ATPASE: A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF DOXORUBICIN-INDUCED CARDIOTOXICITY
by: LENG BIN
Published: (2024)

Molecular basis of cardiotoxicity upon cobra envenomation
by: Cher, C.D.N., et al.
Published: (2012)

Investigation of the pathogenesis caused by exposure to varying doses of VX nerve agent in rat with special reference to cardiotoxicity
by: FONG XIAO JUN
Published: (2010)

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
by: Chan, D., et al.
Published: (2014)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
by: Lehnert, M., et al.
Published: (2014)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
by: Lehnert, M., et al.
Published: (2016)

Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy
by: Chan, A., et al.
Published: (2014)

Complete amino acid sequence of an acidic, cardiotoxic phospholipase A2from the venom of Ophiophagus hannah (King cobra): A novel cobra venom enzyme with 'pancreatic loop'
by: Huang, M.Z., et al.
Published: (2012)

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
by: Aminkeng, Folefac, et al.
Published: (2022)

Predicting Anthracycline-induced Cardiotoxicity in Children - Genome-Wide Association Study
by: Aminkeng, Folefac, et al.
Published: (2022)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
by: Maillet, A, et al.
Published: (2020)

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
by: Chung, R, et al.
Published: (2020)

Lysine 268 adjacent to transmembrane helix 5 of hamster P-glycoprotein is the major photobinding site of iodomycin in CHO B30 cells
by: Demmer, Annette, et al.
Published: (2022)

APPROACHES TO PHARMACOGENOMICS TRANSLATION IN PUBLIC HEALTH
by: TAN-KOI WEI CHUEN
Published: (2017)

SCALABLE TOPOGRAPHY-INDUCED CELL ALIGNMENT FOR TISSUE ENGINEERING APPLICATIONS
by: CHUKWUEMEKA GEORGE ONYEKA ANENE-NZELU
Published: (2014)

INTERROGATING THE CLINICO-GENOMIC LANDSCAPE OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH PHARMACOGENOMICS AND IMMUNOGENOMICS
by: LEE HSIEN REN, SHAWN (LI XIANREN)
Published: (2024)

Singapore pharmacogenomics portal: A web resource for evaluating human genetic variations of genes responsible for drug responses
by: Wong, L.-P., et al.
Published: (2014)

Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice
by: Adesta, Fadhli, et al.
Published: (2022)

Data case Allopurinol Allergy
by: Hardyanto Soebono, Hardyanto
Published: (2022)

Translational aspects of genetic factors in the prediction of drug response variability: A case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia
by: Chan, S.L., et al.
Published: (2014)

Zebrafish for drug toxicity screening: Bridging the in vitro cell-based models and in vivo mammalian models
by: Sukardi, H., et al.
Published: (2014)

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer
by: Wong, N.-S., et al.
Published: (2014)

Human liver-derived cells stably modified for regulated proinsulin secretion function as bioimplants in vivo
by: Chen, X., et al.
Published: (2013)

Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes
by: Di, Y.M., et al.
Published: (2014)

Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid
by: Zhou, S., et al.
Published: (2014)

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
by: Wright, Galen EB, et al.
Published: (2022)

HIV silencing and inducibility are heterogeneous and are affected by factors intrinsic to the virus
by: Norton, N.J., et al.
Published: (2021)

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
by: Drogemoller, Britt I, et al.
Published: (2022)

Post treatment imaging in head and neck tumours
by: Chong, V.F.H.
Published: (2016)

Presence of Mg-calcite and its influence on MICP and EICP processes
by: Wang, Wenhao, et al.
Published: (2025)

Drug ADME-associated protein database as a resource for facilitating pharmacogenomics research
by: Zheng, C.J., et al.
Published: (2014)

Light-operated rotaxanes on graphene
by: Li, Xing
Published: (2013)

Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cells
by: Kitajima, Shojiro, et al.
Published: (2018)